Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Karyotyping01:17

Karyotyping

Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sigma1 Receptor Activation Confers Durable Neuroprotection Following Neonatal Ischemic Retinal Injury.

Research square·2026
Same author

Early Discontinuation of Empiric Antibiotics in Pediatric Haploidentical Hematopoietic Cell Transplant Recipients with Febrile Neutropenia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Association Between Severe Perioperative Surgical Morbidity With Cesarean Delivery and Postpartum Readmission.

Obstetrics and gynecology·2026
Same author

Effects of Tobacco Use on Oral Cancer Screening Algorithm Performance.

Cancers·2026
Same author

A Roadmap for Accelerating Research in Intellectual and Developmental Disabilities Using PCORnet®.

Medical care·2026
Same author

Infant emergency department visits, readmission, and mortality by maternal anxiety disorder during pregnancy occurring with and without other mental health conditions: a retrospective cohort study.

BMC pregnancy and childbirth·2025
Same journal

The Political Determinants of Obstetric Prescribing.

Obstetrics and gynecology·2026
Same journal

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis.

Obstetrics and gynecology·2026
Same journal

Milestones in Motion: Vaginal Birth After Cesarean.

Obstetrics and gynecology·2026
Same journal

Ebola Virus in Pregnancy.

Obstetrics and gynecology·2026
Same journal

A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

Obstetrics and gynecology·2026
Same journal

The Effects of Climate Change on Obstetric and Gynecologic Health.

Obstetrics and gynecology·2026
See all related articles

Related Experiment Video

Updated: Jun 22, 2026

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

Triple-marker prenatal screening program for chromosomal defects.

N Neely Kazerouni1, Bob Currier, Linda Malm

  • 1From the Genetic Disease Screening Program, California Department of Public Health, Richmond, California.

Obstetrics and Gynecology
|June 24, 2009
PubMed
Summary
This summary is machine-generated.

California's triple-marker screening program demonstrated high detection rates for Down syndrome, exceeding predictions. This study provides valuable data for improving prenatal screening accuracy.

More Related Videos

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

Related Experiment Videos

Last Updated: Jun 22, 2026

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
09:03

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

FISH for Pre-implantation Genetic Diagnosis
07:34

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

Area of Science:

  • Prenatal diagnostics
  • Genetics
  • Public health surveillance

Background:

  • The triple-marker screening program in California aims to detect chromosomal abnormalities.
  • Accurate screening is crucial for informed reproductive decisions and timely intervention.

Purpose of the Study:

  • To evaluate the real-world screening performance of California's triple-marker screening program.
  • To analyze detection rates for Down syndrome and other chromosomal defects.

Main Methods:

  • Utilized data from 752,686 women in the California Chromosomal Defect Registry (CCDR) from July 2005 to June 2007.
  • Included follow-up diagnostic outcomes for screen-positive women at state-approved centers.
  • Incorporated data from cytogenetic laboratories, hospitals, and prenatal care providers.

Main Results:

  • Observed Down syndrome detection rate was 77.4%, varying by gestational dating (81.3% ultrasound vs. 67.5% LMP) and maternal age (94.0% ≥35 yrs vs. 62.4% <35 yrs).
  • Detection rates for other trisomies: Turner syndrome (79.4%), trisomy 18 (82.5%), triploidy (98.1%), and trisomy 13 (36.0%).
  • Positive rate for Down syndrome was 5.4%; 49.5% of screen-positive women opted for amniocentesis, with subsequent outcomes including termination (61.4%), live birth (26.2%), and miscarriage/death (4.5%).

Conclusions:

  • California's triple-marker screening program performance for Down syndrome surpassed predicted detection rates.
  • The study methodology will be applied to assess future screening enhancements.
  • Findings highlight the program's effectiveness and provide a benchmark for improvement.